Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/02/049696
CTRI/2023/02/049696
Completed
Phase 2

A Clinical Study to Evaluate the Efficacy and Safety of Polyherbal Unani Formulations in the Management of Qul ? (Aphthous stomatitis)

State Unani Medical College, himmatganj Prayagraj0 sites40 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: K120- Recurrent oral aphthae

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: K120- Recurrent oral aphthae
Sponsor
State Unani Medical College, himmatganj Prayagraj
Enrollment
40
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
State Unani Medical College, himmatganj Prayagraj

Eligibility Criteria

Inclusion Criteria

  • •1\.Patients of any sex in the age group of 18\-65 years
  • •2\.Presence of single/multiple ulcers in the oral cavity or tongue with the presence of any of the following symptoms
  • •Difficulty in any eating/chewing/speaking/swallowing or burning sensation, pain in the oral cavity,coated tongue, excessive salivation
  • •3\.Patients clinically diagnosed with Qul ? (Aphthous stomatitis)

Exclusion Criteria

  • •The following patients will be excluded
  • •1\.Pregnant and lactating mothers.
  • •2\.Patient with severe renal, hepatic, and cardiac disease.
  • •3\.Those who have a history of systematic underlying disease (Crohn’s disease, Ulcerative Colitis, Behcet’s syndrome, Sweet’s Syndrome, Lupus erythematosus) and Diabetes mellitus.
  • •4\.Those diagnosed with oral cavity carcinoma.
  • •5\. Patient of hypertension.
  • •6\.Patient unsure about attending treatment schedule regularly.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
Treatment of ithy, red, dry and cracked skin condition (Eczema) by of Unani drug
CTRI/2017/12/010957Central Research Institute of Unani Medicine
Completed
Phase 2
A Clinical Study to Evaluate the Efficacy and Safety of JR-031 in Patients with Epidermolysis BullosaEpidermolysis Bullosa
JPRN-UMIN000026645Osaka University6
Recruiting
Not Applicable
Evaluation of the usefulness and safety of the combined use of an ear prosthesis and a cartilage conduction hearing aid
JPRN-UMIN000044711Keio University30
Not yet recruiting
Phase 2
Effectiveness of Unani Drugs in High Blood Pressure
CTRI/2017/12/011006Central Research Institute of Unani Medicine
Active, not recruiting
Not Applicable
Study Evaluating Rapamune® Maintenance RegimeRenal transplantationMedDRA version: 17.1Level: PTClassification code 10038533Term: Renal transplantSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]
EUCTR2014-004101-33-Outside-EU/EEAWyeth Korea, Inc.79